| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8776932 | The Breast | 2018 | 7 Pages |
Abstract
We provide evidence that disease progression in patients with metastatic breast cancer in a real-world registry has a significant negative impact on HRQoL as measured by MID of HRQoL. This study emphasizes the relevance of avoiding progression and prolonging PFS to maintain QoL.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Volkmar Müller, Naiba Nabieva, Lothar Häberle, Florin-Andrei Taran, Andreas D. Hartkopf, Bernhard Volz, Friedrich Overkamp, Anna Lisa Brandl, Hans-Christian Kolberg, Peyman Hadji, Hans Tesch, Johannes Ettl, Michael P. Lux, Diana Lüftner,